Skip to main content

Articles

Page 5 of 20

  1. Authors: Robert Sauermann, Thomas Feurstein, Rudolf Karch, Andreas Püspök, Herbert Langenberger, Walter Jäger, Michaela Böhmdorfer, Thomas Wild, Stefan Winkler, Maria C Kjellsson and Markus Zeitlinger
    Citation: BMC Pharmacology 2010 10(Suppl 1):A48

    This article is part of a Supplement: Volume 10 Supplement 1

  2. Authors: Semira Kaya, Günther Weigert, Nikolaus Dragostinoff, René Werkmeister, Berthold Pemp, Stefan Sacu, Gerhard Garhöfer, Ursula Schmidt-Erfurth and Leopold Schmetterer
    Citation: BMC Pharmacology 2010 10(Suppl 1):A40

    This article is part of a Supplement: Volume 10 Supplement 1

  3. Sunitinib, a tyrosine kinase inhibitor to treat GIST and mRCC may interact with paracetamol as both undergo P450 mediated biotransformation and P-glycoprotein transport. This study evaluates the effects of sun...

    Authors: Adeline YL Lim, Ignacio Segarra, Srikumar Chakravarthi, Sufyan Akram and John P Judson
    Citation: BMC Pharmacology 2010 10:14
  4. Carbon tetra chloride (CCl4), an industrial solvent, is a hepatotoxic agent and it is the well established animal model for free radical-induced liver injury. The present investigation was carried out to establis...

    Authors: Polimetla Srilaxmi, Gangadhara Reddy Sareddy, Polavarapu Bilhan Kavi kishor, Oruganti Hussainaiah Setty and Phanithi Prakash Babu
    Citation: BMC Pharmacology 2010 10:13
  5. ATP-binding cassette (ABC) transporters protect cells against unrelated (toxic) substances by pumping them across cell membranes. Earlier we showed that many ABC transporters are highly expressed in hematopoie...

    Authors: Leilei Tang, Saskia M Bergevoet, Christian Gilissen, Theo de Witte, Joop H Jansen, Bert A van der Reijden and Reinier AP Raymakers
    Citation: BMC Pharmacology 2010 10:12
  6. Although agmatine therapy in a mouse model of transient focal cerebral ischemia is highly protective against neurological injury, the mechanisms underlying the protective effects of agmatine are not fully eluc...

    Authors: Che-Chuan Wang, Chung-Ching Chio, Ching-Hong Chang, Jinn-Rung Kuo and Ching-Ping Chang
    Citation: BMC Pharmacology 2010 10:11
  7. Infarct-induced left ventricular (LV) remodeling is a deleterious consequence after acute myocardial infarction (MI) which may further advance to congestive heart failure. Therefore, new therapeutic strategies...

    Authors: Baohong Jiang, Jing Chen, Lingling Xu, Zhenting Gao, Yanping Deng, Yanhui Wang, Feng Xu, Xu Shen and De-an Guo
    Citation: BMC Pharmacology 2010 10:10
  8. Cannabinoid 1 (CB1) receptor antagonists exhibit pharmacological properties favorable for the treatment of obesity and other related metabolic disorders. CE-178253 (1-[7-(2-Chlorophenyl)-8-(4-chlorophenyl)-2-meth...

    Authors: John R Hadcock, Philip A Carpino, Philip A Iredale, Robert L Dow, Denise Gautreau, Lucinda Thiede, Dawn Kelly-Sullivan, Jeffrey S Lizano, Xingrong Liu, Jeffrey Van Deusen, Karen M Ward, Rebecca E O'Connor, Shawn C Black, David A Griffith and Dennis O Scott
    Citation: BMC Pharmacology 2010 10:9